nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HTR2C—metabolic syndrome X	0.728	1	CbGaD
Paliperidone—Tonsillitis—Metformin—metabolic syndrome X	0.00851	0.0875	CcSEcCtD
Paliperidone—HTR2A—arteriole—metabolic syndrome X	0.00776	0.145	CbGeAlD
Paliperidone—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00494	0.0925	CbGeAlD
Paliperidone—HTR1B—artery—metabolic syndrome X	0.00392	0.0733	CbGeAlD
Paliperidone—Body temperature decreased—Metformin—metabolic syndrome X	0.00384	0.0394	CcSEcCtD
Paliperidone—Hypothermia—Metformin—metabolic syndrome X	0.00384	0.0394	CcSEcCtD
Paliperidone—HTR1D—artery—metabolic syndrome X	0.00379	0.071	CbGeAlD
Paliperidone—Toothache—Metformin—metabolic syndrome X	0.00354	0.0363	CcSEcCtD
Paliperidone—Respiratory distress—Metformin—metabolic syndrome X	0.00339	0.0348	CcSEcCtD
Paliperidone—HTR2A—autonomic nervous system—metabolic syndrome X	0.00332	0.0622	CbGeAlD
Paliperidone—Upset stomach—Metformin—metabolic syndrome X	0.00328	0.0337	CcSEcCtD
Paliperidone—HTR1B—blood vessel—metabolic syndrome X	0.00305	0.0571	CbGeAlD
Paliperidone—HTR1D—blood vessel—metabolic syndrome X	0.00296	0.0553	CbGeAlD
Paliperidone—Risperidone—HTR2C—metabolic syndrome X	0.00269	0.516	CrCbGaD
Paliperidone—Iloperidone—HTR2C—metabolic syndrome X	0.00252	0.484	CrCbGaD
Paliperidone—Chest discomfort—Metformin—metabolic syndrome X	0.00243	0.025	CcSEcCtD
Paliperidone—HTR2A—artery—metabolic syndrome X	0.00188	0.0353	CbGeAlD
Paliperidone—Ear pain—Metformin—metabolic syndrome X	0.00183	0.0188	CcSEcCtD
Paliperidone—ADRA1B—kidney—metabolic syndrome X	0.00176	0.033	CbGeAlD
Paliperidone—Nasal congestion—Metformin—metabolic syndrome X	0.00171	0.0176	CcSEcCtD
Paliperidone—Hypoglycaemia—Metformin—metabolic syndrome X	0.0016	0.0164	CcSEcCtD
Paliperidone—Lethargy—Metformin—metabolic syndrome X	0.00159	0.0164	CcSEcCtD
Paliperidone—HTR2A—endothelium—metabolic syndrome X	0.00159	0.0298	CbGeAlD
Paliperidone—Pain in extremity—Metformin—metabolic syndrome X	0.00156	0.016	CcSEcCtD
Paliperidone—HTR2A—blood vessel—metabolic syndrome X	0.00147	0.0275	CbGeAlD
Paliperidone—Abdominal pain upper—Metformin—metabolic syndrome X	0.00143	0.0146	CcSEcCtD
Paliperidone—Breast disorder—Metformin—metabolic syndrome X	0.00141	0.0145	CcSEcCtD
Paliperidone—Nasopharyngitis—Metformin—metabolic syndrome X	0.0014	0.0143	CcSEcCtD
Paliperidone—HTR1B—cardiovascular system—metabolic syndrome X	0.00136	0.0255	CbGeAlD
Paliperidone—Influenza—Metformin—metabolic syndrome X	0.00135	0.0139	CcSEcCtD
Paliperidone—Pancreatitis—Metformin—metabolic syndrome X	0.00132	0.0136	CcSEcCtD
Paliperidone—HTR1D—cardiovascular system—metabolic syndrome X	0.00132	0.0247	CbGeAlD
Paliperidone—Abdominal discomfort—Metformin—metabolic syndrome X	0.00129	0.0133	CcSEcCtD
Paliperidone—HTR1D—kidney—metabolic syndrome X	0.00129	0.0241	CbGeAlD
Paliperidone—Neutropenia—Metformin—metabolic syndrome X	0.00126	0.013	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00125	0.0129	CcSEcCtD
Paliperidone—Infestation—Metformin—metabolic syndrome X	0.0012	0.0124	CcSEcCtD
Paliperidone—Infestation NOS—Metformin—metabolic syndrome X	0.0012	0.0124	CcSEcCtD
Paliperidone—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00114	0.0117	CcSEcCtD
Paliperidone—Bradycardia—Metformin—metabolic syndrome X	0.0011	0.0113	CcSEcCtD
Paliperidone—HTR1A—cardiovascular system—metabolic syndrome X	0.0011	0.0206	CbGeAlD
Paliperidone—Rhinitis—Metformin—metabolic syndrome X	0.00108	0.0111	CcSEcCtD
Paliperidone—Hypoaesthesia—Metformin—metabolic syndrome X	0.00107	0.011	CcSEcCtD
Paliperidone—Oedema peripheral—Metformin—metabolic syndrome X	0.00106	0.0109	CcSEcCtD
Paliperidone—Connective tissue disorder—Metformin—metabolic syndrome X	0.00106	0.0109	CcSEcCtD
Paliperidone—ADRA1A—cardiovascular system—metabolic syndrome X	0.00101	0.019	CbGeAlD
Paliperidone—Eye disorder—Metformin—metabolic syndrome X	0.00101	0.0104	CcSEcCtD
Paliperidone—Cardiac disorder—Metformin—metabolic syndrome X	0.001	0.0103	CcSEcCtD
Paliperidone—Flushing—Metformin—metabolic syndrome X	0.001	0.0103	CcSEcCtD
Paliperidone—Angiopathy—Metformin—metabolic syndrome X	0.00098	0.0101	CcSEcCtD
Paliperidone—Immune system disorder—Metformin—metabolic syndrome X	0.000976	0.01	CcSEcCtD
Paliperidone—Mediastinal disorder—Metformin—metabolic syndrome X	0.000973	0.01	CcSEcCtD
Paliperidone—Chills—Metformin—metabolic syndrome X	0.000969	0.00996	CcSEcCtD
Paliperidone—ADRA2C—kidney—metabolic syndrome X	0.000945	0.0177	CbGeAlD
Paliperidone—Malnutrition—Metformin—metabolic syndrome X	0.00094	0.00966	CcSEcCtD
Paliperidone—Erythema—Metformin—metabolic syndrome X	0.00094	0.00966	CcSEcCtD
Paliperidone—Flatulence—Metformin—metabolic syndrome X	0.000926	0.00952	CcSEcCtD
Paliperidone—Dysgeusia—Metformin—metabolic syndrome X	0.000921	0.00946	CcSEcCtD
Paliperidone—Muscle spasms—Metformin—metabolic syndrome X	0.000904	0.00929	CcSEcCtD
Paliperidone—ADRA1A—adipose tissue—metabolic syndrome X	0.000893	0.0167	CbGeAlD
Paliperidone—Vision blurred—Metformin—metabolic syndrome X	0.000886	0.0091	CcSEcCtD
Paliperidone—Tremor—Metformin—metabolic syndrome X	0.000881	0.00905	CcSEcCtD
Paliperidone—Ill-defined disorder—Metformin—metabolic syndrome X	0.000872	0.00896	CcSEcCtD
Paliperidone—ADRA2C—adipose tissue—metabolic syndrome X	0.000851	0.0159	CbGeAlD
Paliperidone—Malaise—Metformin—metabolic syndrome X	0.000848	0.00871	CcSEcCtD
Paliperidone—Syncope—Metformin—metabolic syndrome X	0.000843	0.00866	CcSEcCtD
Paliperidone—Palpitations—Metformin—metabolic syndrome X	0.000831	0.00854	CcSEcCtD
Paliperidone—Loss of consciousness—Metformin—metabolic syndrome X	0.000826	0.00849	CcSEcCtD
Paliperidone—Hypertension—Metformin—metabolic syndrome X	0.000812	0.00834	CcSEcCtD
Paliperidone—Chest pain—Metformin—metabolic syndrome X	0.0008	0.00822	CcSEcCtD
Paliperidone—Myalgia—Metformin—metabolic syndrome X	0.0008	0.00822	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000795	0.00817	CcSEcCtD
Paliperidone—Discomfort—Metformin—metabolic syndrome X	0.000791	0.00812	CcSEcCtD
Paliperidone—CYP3A5—kidney—metabolic syndrome X	0.000791	0.0148	CbGeAlD
Paliperidone—Oedema—Metformin—metabolic syndrome X	0.000767	0.00788	CcSEcCtD
Paliperidone—Infection—Metformin—metabolic syndrome X	0.000762	0.00783	CcSEcCtD
Paliperidone—Shock—Metformin—metabolic syndrome X	0.000755	0.00776	CcSEcCtD
Paliperidone—Nervous system disorder—Metformin—metabolic syndrome X	0.000753	0.00773	CcSEcCtD
Paliperidone—Thrombocytopenia—Metformin—metabolic syndrome X	0.000751	0.00772	CcSEcCtD
Paliperidone—Skin disorder—Metformin—metabolic syndrome X	0.000745	0.00766	CcSEcCtD
Paliperidone—Anorexia—Metformin—metabolic syndrome X	0.000731	0.00751	CcSEcCtD
Paliperidone—Hypotension—Metformin—metabolic syndrome X	0.000717	0.00737	CcSEcCtD
Paliperidone—CYP3A5—adipose tissue—metabolic syndrome X	0.000713	0.0133	CbGeAlD
Paliperidone—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000699	0.00718	CcSEcCtD
Paliperidone—HRH1—adipose tissue—metabolic syndrome X	0.000692	0.0129	CbGeAlD
Paliperidone—Paraesthesia—Metformin—metabolic syndrome X	0.000689	0.00708	CcSEcCtD
Paliperidone—Dyspnoea—Metformin—metabolic syndrome X	0.000684	0.00703	CcSEcCtD
Paliperidone—Somnolence—Metformin—metabolic syndrome X	0.000682	0.00701	CcSEcCtD
Paliperidone—ADRA2A—adipose tissue—metabolic syndrome X	0.000679	0.0127	CbGeAlD
Paliperidone—Dyspepsia—Metformin—metabolic syndrome X	0.000675	0.00694	CcSEcCtD
Paliperidone—Decreased appetite—Metformin—metabolic syndrome X	0.000667	0.00685	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000662	0.00681	CcSEcCtD
Paliperidone—Fatigue—Metformin—metabolic syndrome X	0.000662	0.0068	CcSEcCtD
Paliperidone—Constipation—Metformin—metabolic syndrome X	0.000656	0.00674	CcSEcCtD
Paliperidone—HTR2A—cardiovascular system—metabolic syndrome X	0.000655	0.0123	CbGeAlD
Paliperidone—HTR2A—kidney—metabolic syndrome X	0.000641	0.012	CbGeAlD
Paliperidone—Feeling abnormal—Metformin—metabolic syndrome X	0.000632	0.0065	CcSEcCtD
Paliperidone—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000627	0.00645	CcSEcCtD
Paliperidone—ADRA1A—liver—metabolic syndrome X	0.000627	0.0117	CbGeAlD
Paliperidone—Urticaria—Metformin—metabolic syndrome X	0.00061	0.00626	CcSEcCtD
Paliperidone—Abdominal pain—Metformin—metabolic syndrome X	0.000607	0.00623	CcSEcCtD
Paliperidone—ADRA2C—liver—metabolic syndrome X	0.000597	0.0112	CbGeAlD
Paliperidone—CYP3A4—kidney—metabolic syndrome X	0.000593	0.0111	CbGeAlD
Paliperidone—CYP2D6—kidney—metabolic syndrome X	0.000584	0.0109	CbGeAlD
Paliperidone—Asthenia—Metformin—metabolic syndrome X	0.000551	0.00566	CcSEcCtD
Paliperidone—Pruritus—Metformin—metabolic syndrome X	0.000543	0.00558	CcSEcCtD
Paliperidone—Diarrhoea—Metformin—metabolic syndrome X	0.000525	0.00539	CcSEcCtD
Paliperidone—Dizziness—Metformin—metabolic syndrome X	0.000507	0.00521	CcSEcCtD
Paliperidone—CYP3A5—liver—metabolic syndrome X	0.0005	0.00935	CbGeAlD
Paliperidone—Vomiting—Metformin—metabolic syndrome X	0.000488	0.00501	CcSEcCtD
Paliperidone—Rash—Metformin—metabolic syndrome X	0.000484	0.00497	CcSEcCtD
Paliperidone—Dermatitis—Metformin—metabolic syndrome X	0.000483	0.00497	CcSEcCtD
Paliperidone—Headache—Metformin—metabolic syndrome X	0.000481	0.00494	CcSEcCtD
Paliperidone—Nausea—Metformin—metabolic syndrome X	0.000456	0.00468	CcSEcCtD
Paliperidone—HTR2A—liver—metabolic syndrome X	0.000405	0.00758	CbGeAlD
Paliperidone—CYP3A4—liver—metabolic syndrome X	0.000375	0.00701	CbGeAlD
Paliperidone—CYP2D6—liver—metabolic syndrome X	0.000369	0.0069	CbGeAlD
Paliperidone—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.41e-05	0.000122	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—APOE—metabolic syndrome X	1.41e-05	0.000121	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—LEP—metabolic syndrome X	1.41e-05	0.000121	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IGF1—metabolic syndrome X	1.4e-05	0.000121	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.4e-05	0.00012	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	1.39e-05	0.00012	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.39e-05	0.00012	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.39e-05	0.000119	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.38e-05	0.000119	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.38e-05	0.000119	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.37e-05	0.000118	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	1.37e-05	0.000118	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.35e-05	0.000116	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PPARA—metabolic syndrome X	1.34e-05	0.000116	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ALB—metabolic syndrome X	1.34e-05	0.000115	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.33e-05	0.000115	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.33e-05	0.000115	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.33e-05	0.000115	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.33e-05	0.000114	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	1.32e-05	0.000114	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.31e-05	0.000113	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	1.31e-05	0.000113	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.3e-05	0.000112	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AGT—metabolic syndrome X	1.3e-05	0.000112	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AGT—metabolic syndrome X	1.3e-05	0.000112	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.3e-05	0.000112	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.3e-05	0.000112	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.3e-05	0.000112	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NOS3—metabolic syndrome X	1.29e-05	0.000111	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	1.29e-05	0.000111	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.28e-05	0.000111	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—NOS3—metabolic syndrome X	1.28e-05	0.00011	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.28e-05	0.00011	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.28e-05	0.00011	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.28e-05	0.00011	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	1.28e-05	0.00011	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—LEP—metabolic syndrome X	1.27e-05	0.00011	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—APOE—metabolic syndrome X	1.27e-05	0.00011	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—APOE—metabolic syndrome X	1.27e-05	0.00011	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.27e-05	0.00011	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	1.27e-05	0.00011	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.27e-05	0.000109	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.26e-05	0.000109	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	0.000109	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	0.000109	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—APOA1—metabolic syndrome X	1.26e-05	0.000108	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.26e-05	0.000108	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.26e-05	0.000108	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	1.25e-05	0.000108	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.25e-05	0.000108	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.25e-05	0.000108	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.25e-05	0.000107	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.24e-05	0.000107	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.24e-05	0.000107	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.24e-05	0.000107	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	1.23e-05	0.000106	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.23e-05	0.000106	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.22e-05	0.000105	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.22e-05	0.000105	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.22e-05	0.000105	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.21e-05	0.000104	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	1.21e-05	0.000104	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	0.000104	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.2e-05	0.000104	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.2e-05	0.000104	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—INS—metabolic syndrome X	1.19e-05	0.000102	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.19e-05	0.000102	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	0.000102	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.18e-05	0.000102	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.18e-05	0.000102	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.17e-05	0.000101	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.16e-05	0.0001	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	0.0001	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.16e-05	0.0001	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.16e-05	0.0001	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.16e-05	0.0001	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.16e-05	9.98e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.16e-05	9.97e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.16e-05	9.97e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.16e-05	9.96e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.15e-05	9.95e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.15e-05	9.91e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.15e-05	9.9e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	1.15e-05	9.89e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	9.82e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	9.8e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	1.13e-05	9.75e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.13e-05	9.75e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.12e-05	9.67e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.12e-05	9.62e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.12e-05	9.61e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	1.11e-05	9.59e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PPARG—metabolic syndrome X	1.11e-05	9.56e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.11e-05	9.56e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.11e-05	9.55e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.11e-05	9.52e-05	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.1e-05	9.51e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.1e-05	9.5e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.1e-05	9.48e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	9.4e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.09e-05	9.4e-05	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	1.09e-05	9.38e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	9.38e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.09e-05	9.38e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—INS—metabolic syndrome X	1.09e-05	9.38e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	1.09e-05	9.36e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.08e-05	9.31e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	9.25e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	9.24e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	1.07e-05	9.24e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.07e-05	9.24e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	9.23e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.07e-05	9.22e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.07e-05	9.21e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.06e-05	9.1e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	9.09e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	1.05e-05	9.08e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	9.06e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.04e-05	8.97e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.04e-05	8.95e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.04e-05	8.93e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.03e-05	8.91e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.03e-05	8.85e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.02e-05	8.78e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.01e-05	8.7e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.01e-05	8.7e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	1e-05	8.64e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1e-05	8.64e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	1e-05	8.62e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ALB—metabolic syndrome X	9.98e-06	8.6e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	9.93e-06	8.55e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	9.89e-06	8.52e-05	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.83e-06	8.47e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	9.82e-06	8.46e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.82e-06	8.46e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	9.77e-06	8.42e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	9.73e-06	8.38e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	9.68e-06	8.34e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	9.62e-06	8.29e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	9.6e-06	8.27e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	9.57e-06	8.25e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	9.55e-06	8.23e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARA—metabolic syndrome X	9.54e-06	8.22e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—NOS3—metabolic syndrome X	9.54e-06	8.22e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	9.52e-06	8.21e-05	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.49e-06	8.18e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	9.46e-06	8.15e-05	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.44e-06	8.14e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	9.37e-06	8.07e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	9.34e-06	8.05e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	9.3e-06	8.01e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AGT—metabolic syndrome X	9.24e-06	7.96e-05	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.19e-06	7.91e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.12e-06	7.86e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOE—metabolic syndrome X	9.06e-06	7.8e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	9.04e-06	7.79e-05	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.04e-06	7.79e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	9e-06	7.76e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	9e-06	7.76e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOA1—metabolic syndrome X	8.95e-06	7.71e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	8.93e-06	7.69e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	8.9e-06	7.67e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	8.73e-06	7.52e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.72e-06	7.51e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.72e-06	7.51e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	8.71e-06	7.5e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.62e-06	7.43e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.58e-06	7.39e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	8.52e-06	7.34e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	8.4e-06	7.24e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.34e-06	7.19e-05	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.33e-06	7.18e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.21e-06	7.07e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	8.2e-06	7.07e-05	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.2e-06	7.07e-05	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.18e-06	7.05e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.07e-06	6.96e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	8.05e-06	6.94e-05	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.03e-06	6.92e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	7.9e-06	6.81e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—metabolic syndrome X	7.89e-06	6.8e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—INS—metabolic syndrome X	7.74e-06	6.67e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	7.59e-06	6.54e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	7.57e-06	6.52e-05	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.46e-06	6.43e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.45e-06	6.42e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	7.43e-06	6.4e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	7.4e-06	6.38e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.4e-06	6.37e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	7.34e-06	6.33e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	7.33e-06	6.31e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.29e-06	6.28e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.29e-06	6.28e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	7.25e-06	6.24e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.2e-06	6.2e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—metabolic syndrome X	7.13e-06	6.14e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.09e-06	6.11e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.09e-06	6.11e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—LPL—metabolic syndrome X	7.06e-06	6.09e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	6.98e-06	6.01e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	6.83e-06	5.88e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NOS3—metabolic syndrome X	6.79e-06	5.85e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.78e-06	5.84e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.71e-06	5.78e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	6.68e-06	5.76e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	6.58e-06	5.67e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	6.43e-06	5.54e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—metabolic syndrome X	6.42e-06	5.53e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—metabolic syndrome X	6.33e-06	5.46e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.33e-06	5.45e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	6.31e-06	5.44e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.24e-06	5.38e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.21e-06	5.35e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.2e-06	5.34e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AGT—metabolic syndrome X	6.04e-06	5.21e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	5.92e-06	5.1e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.92e-06	5.1e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AKT1—metabolic syndrome X	5.89e-06	5.08e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.85e-06	5.04e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	5.84e-06	5.03e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.76e-06	4.96e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	5.72e-06	4.93e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	5.52e-06	4.76e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.49e-06	4.73e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	5.34e-06	4.6e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	5.28e-06	4.55e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	5.26e-06	4.53e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.16e-06	4.44e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	5.09e-06	4.39e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.07e-06	4.37e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—INS—metabolic syndrome X	5.06e-06	4.36e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	4.93e-06	4.25e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	4.85e-06	4.18e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—metabolic syndrome X	4.85e-06	4.18e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.79e-06	4.12e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.77e-06	4.11e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.76e-06	4.1e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.67e-06	4.02e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.64e-06	4e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.47e-06	3.85e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.44e-06	3.82e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.4e-06	3.79e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	4.39e-06	3.78e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AKT1—metabolic syndrome X	4.39e-06	3.78e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.34e-06	3.74e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.31e-06	3.71e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.06e-06	3.5e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4e-06	3.45e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.12e-06	2.69e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.04e-06	1.76e-05	CbGpPWpGaD
